| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/31/1997 | WO1997027300A1 TOXOPLASMA GONDII ANTIGEN Tg20 |
| 07/31/1997 | WO1997027299A1 Mammalian cx3c chemokine genes |
| 07/31/1997 | WO1997027296A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | WO1997027287A1 Cauliflower floral meristem identity genes and methods of using same |
| 07/31/1997 | WO1997027218A1 Method for evaluating and affecting male fertility |
| 07/31/1997 | WO1997027215A1 Nucleotide and amino acid sequences of t. pallidum rare outer membrane protein |
| 07/31/1997 | WO1997027208A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | WO1997026914A1 Methods and compositions for passive immunotherapy |
| 07/31/1997 | WO1997026913A1 A POLYPEPTIDE FROM LUNG EXTRACT WHICH BINDS AMYLOID-β PEPTIDE |
| 07/31/1997 | WO1997026912A2 Anti-cd18 antibodies for use against stroke |
| 07/31/1997 | WO1997026911A1 Malaria vaccine based upon the addition of a msa1 peptide |
| 07/31/1997 | WO1997026853A2 Dna encoding galanin galr2 receptors and uses thereof |
| 07/31/1997 | DE19545351C1 Eukaryotische Zellen mit Hybridrezeptor und dadurch steuerbarem Genkonstrukt, Verfahren zu deren Herstellung und Verwendung dieser Zellen in der Gentherapie Eukaryotic cells with hybrid receptor and thereby controllable gene construct, to processes for their preparation and use of these cells for gene therapy |
| 07/31/1997 | CA2244412A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
| 07/31/1997 | CA2244373A1 Unique associated kaposi's sarcoma virus sequences and uses thereof |
| 07/31/1997 | CA2244147A1 Decorin binding protein compositions and methods of use |
| 07/31/1997 | CA2243557A1 Methods and compositions for passive immunotherapy |
| 07/31/1997 | CA2242200A1 Toxoplasma gondii antigen tg20 |
| 07/31/1997 | CA2216227A1 Dna encoding galanin galr2 receptors and uses thereof |
| 07/30/1997 | EP0786519A2 Staphylococcus aureus polynucleotides and sequences |
| 07/30/1997 | EP0786472A1 Vaccines and diagnostic assays for Haemophilus influenzae |
| 07/30/1997 | EP0786469A2 Nucleic acid ligands |
| 07/30/1997 | EP0786255A1 Methods of improving allograft or xenograft tolerance by administration of an LFA-3 or CD2 binding protein |
| 07/30/1997 | EP0786088A2 Presentation of hydrophobic antigens to t-cells by cd1 molecules |
| 07/30/1997 | EP0786087A1 Polypeptide-dendrimer complexes |
| 07/30/1997 | EP0786084A1 Method for screening compositions |
| 07/30/1997 | EP0786010A1 Cell-type specific gene transfer using retroviral vectors containing antibody-envelope and wild-type envelope-fusion proteins |
| 07/30/1997 | EP0786004A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 07/30/1997 | EP0785993A1 Monoclonal antibodies to thymidine kinase isozymes |
| 07/30/1997 | EP0785990A1 Method for stimulating profileration of colon cells using pomc 76-103 |
| 07/30/1997 | EP0785716A1 Cytokine designated lerk-6 |
| 07/30/1997 | EP0481089B1 Human monoclonal antibody against glycoprotein gp iii of varicella zoster virus |
| 07/30/1997 | CN1155931A Preparation of derivatized 10,10'-substituted-9,9'-biacridine luminescent molecules and signal solutions |
| 07/30/1997 | CN1155904A LAG-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 07/30/1997 | CN1155550A Preparation of specificity antivirus factor from yolks |
| 07/29/1997 | US5652373 Destroying hematopoietic cells and replacing them with cells from at least one other species |
| 07/29/1997 | US5652361 Macrocyclic ligands and complexes |
| 07/29/1997 | US5652357 Nucleic acids for the detection of the Bak polymorphism in human platelet membrane glycoprotein IIb |
| 07/29/1997 | US5652352 Afamin: a human serum albumin-like gene |
| 07/29/1997 | US5652343 Method for purification of L-selectin ligands |
| 07/29/1997 | US5652342 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same |
| 07/29/1997 | US5652340 Matrix-associating DNA-binding protein, nucleic acids encoding the same and methods for detecting the nucleic acids |
| 07/29/1997 | US5652338 Neutrophil chemotactic factor |
| 07/29/1997 | US5652337 OP-3-induced morphogenesis |
| 07/29/1997 | US5652333 gC1q receptor, HIV-1 gp120 region binding thereto, and related peptides and targeting antibodies |
| 07/29/1997 | US5652223 DNA encoding CAI resistance proteins and uses thereof |
| 07/29/1997 | US5652210 Soluble splice variant of the Fas (APO-1) antigen, FasΔTM |
| 07/29/1997 | US5652138 Immunoreacts with human immunodeficiency virus glycoprotein |
| 07/29/1997 | US5652134 Hybridomas producing bluetongue virus-specific monoclonals |
| 07/29/1997 | US5652131 Cyclic GMP-binding, cyclic GMP-specific phosphodiesterase materials and methods |
| 07/29/1997 | US5652123 Protein having interleukin 13 activity, recombinant DNA coding for this protein, transformed cells and microorganisms |
| 07/29/1997 | US5652118 Nucleic acid encoding a novel morphogenic protein, OP-3 |
| 07/29/1997 | US5652117 Human transcription factor IIA |
| 07/29/1997 | US5652114 Diagnostic immunoassay methods using monoclonal antibody F36/22 which is specific for human breast carcinoma cells |
| 07/29/1997 | US5652113 Contacting nonneuronal cells expressing on their cell surface the human serotonin receptor with chemical compound under conditions suitable for binding, detecting specific binding of compound to receptor |
| 07/29/1997 | US5652112 Assay for type I collagen carboxy-terminal telopeptide analytes |
| 07/29/1997 | US5652111 System for detecting compounds that are potassium channel modulators |
| 07/29/1997 | US5652110 Antibodies to αvβ3 integrin |
| 07/29/1997 | US5652109 Antitumor agents; medical diagnosis |
| 07/29/1997 | US5652092 Amyloid precursor proteins and method of using same to assess agents which down-regulate formation of β-amyloid peptide |
| 07/29/1997 | US5651970 Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics |
| 07/29/1997 | US5651969 Enhancing neurite outgrowth and improving nerve regeneration |
| 07/29/1997 | CA1339188C Removal of protein a from antibody preparations |
| 07/29/1997 | CA1339098C Characterization and detection of sequences associated with autoimmune diseases |
| 07/29/1997 | CA1339095C Purification of cancer-associated protein and preparation of antibody thereto |
| 07/29/1997 | CA1339094C In vitro human monoclonal igg rheumatoid factor autoantibody |
| 07/29/1997 | CA1339069C Polypeptide-induced monoclonal receptors to protein ligand |
| 07/26/1997 | CA2195727A1 Process for extending the assay range and for avoiding the hook effect in simultaneous sandwich immunoassays, and corresponding test kits |
| 07/24/1997 | WO1997026523A2 Detection of a leptin receptor variant and methods for regulating obesity |
| 07/24/1997 | WO1997026370A1 Leptin receptor variants |
| 07/24/1997 | WO1997026359A1 System for the expression of heterologous antigens as fusion proteins |
| 07/24/1997 | WO1997026356A1 PHENYLALANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026355A1 NOVEL VALYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026354A1 HISTIDYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026353A1 ALANYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026352A1 STAPHYLOCOCCUS AUREUS SERYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026351A1 STAPHYLOCOCCUS AUREUS TYROSYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026350A1 STAPHYLOCOCCUS AUREUS METHIONYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026349A1 LEUCYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026348A1 ASPARAGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026347A1 ARGINYL tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026346A1 NOVEL TRYPTOPHANYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026345A1 GLUTAMYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026344A1 ASPARTYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026343A1 NOVEL PROLYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026342A1 THREONYL-tRNA SYNTHETASE OF STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026341A1 CYSTEINYL-tRNA SYNTHETASE FROM STAPHYLOCOCCUS AUREUS |
| 07/24/1997 | WO1997026340A1 STAPHYLOCOCCUS AUREUS GLYCYL-tRNA SYNTHETASE |
| 07/24/1997 | WO1997026338A1 Staphylococcus aureus wcuh29 spoiiie protein |
| 07/24/1997 | WO1997026335A1 Db, the receptor for leptin, nucleic acids encoding the receptor, and uses thereof |
| 07/24/1997 | WO1997026331A2 Use of neuronal apoptosis inhibitor protein (naip) |
| 07/24/1997 | WO1997026329A1 Monoclonal antibody to herpes simplex virus and cell line producing same |
| 07/24/1997 | WO1997026326A1 Isolation of precursor cells from hematopoietic and non-hematopoietic tissues and their use |
| 07/24/1997 | WO1997026274A1 Leptospiral outer membrane proteins |
| 07/24/1997 | WO1997026273A1 Borrelia burgdorferi outer membrane proteins |
| 07/24/1997 | WO1997026272A1 Leptin receptor variants |
| 07/24/1997 | WO1997026010A1 Anticoagulant agents useful in treatment of thrombosis |
| 07/24/1997 | WO1997026009A1 Compounds capable of inhibiting hiv-1 infection |
| 07/24/1997 | WO1997026007A1 Mycobacterium antigens and methods for their detection |
| 07/24/1997 | WO1997026000A1 Therapeutic applications of t-bam (cd40-l) technology to treat inflammatory kidney diseases______________________________________ |